Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.

25 June 2024 | Tuesday | News

Expansion to Add Six New Sites, Enhancing Jubilant's Network to Meet Rising Demand for Advanced Diagnostic and Therapeutic Imaging Solutions
Image Source : Public Domain

Image Source : Public Domain

Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manufacturing facilities by adding six (6) sites in strategic locations throughout the United States. The new PET radiopharmaceutical manufacturing facilities are expected to be operational within 24 months.

The US radiopharmaceutical industry is poised to grow from $5 billion (USD) in 2023 to $20 billion (USD) in 2030 due to the increasing demand of PET imaging and advanced radiopharmaceutical therapies. The growth in the PET imaging market is fueled by new products such as diagnostic agents indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and novel diagnostics that reliably visualize β-amyloid neuritic plaques for more personalized patient management in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.

This investment will expand the company’s PET radiopharmaceutical manufacturing sites to nine (9) and the overall radiopharmacy (PET/SPECT) network to fifty-two (52) sites, solidly positioning Jubilant’s radiopharmacy network as the second largest in the US.

Harsher Singh, CEO, Jubilant Radiopharma business said, “This investment shall help us meet increasing demand of novel PET products from our customers. With a much stronger PET manufacturing network, we also expect to secure long-term contracts with leading PET radiopharmaceutical manufacturers. We remain committed to improve patient lives through nuclear medicine.”


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in